Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026)
Kamada's (KMDA) quarterly Depreciation & Amortization (CF) came in at $3.9 million in Q1 2026, up 6.65% YoY from $3.6 million in Q1 2025, and up 1.32% on a QoQ basis from $3.8 million in Q4 2025.
Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 6.65% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.2 million (up 6.88% YoY) and the FY2025 annual result came in at $14.9 million, up 8.04% from the prior year.
- Depreciation & Amortization (CF) advanced to $3.9 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.1 million in Q4 2024 to a low of $3012.0 in Q4 2022.
- A 5-year average of $2.8 million and a median of $3.2 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 106407.3% in 2023, down 99.9% in 2023.
- Tracing KMDA's Depreciation & Amortization (CF) over 5 years: stood at $3012.0 in 2022, then jumped by 106407.3% to $3.2 million in 2023, then rose by 27.81% to $4.1 million in 2024, then fell by 7.29% to $3.8 million in 2025, then advanced by 1.32% to $3.9 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.9 million (Q1 2026), $3.8 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Kamada | 465.93 Mn | 436.45 Mn | 22.47 Mn | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85 Mn |
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Dec 31, 2023 | 3.21 Mn |